Selenium levels during the course of radiotherapy: No influence of irradiation on blood selenium concentration

Strahlentherapie und Onkologie

Volumn 184, Issue 8, 2008, Pages 411-415

  Fraunholz, Ingeborg ^a   Eberlein, Klaus ^a   Schopohl, Bernd ^a   Böttcher, Heinz Dietrich ^a   Rödel, Claus ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Antioxidants; Complementary alternative medicine; Radiotherapy; Selenium

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; SELENIUM; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD LEVEL; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL PROTOCOL; CORRELATION ANALYSIS; ENDOMETRIUM CANCER; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; PARAMETER; RADIATION DOSE; SELENIUM DEFICIENCY; SEX DIFFERENCE; UTERINE CERVIX CANCER; BLOOD; BREAST TUMOR; CANCER STAGING; HEAD AND NECK TUMOR; LYMPH NODE METASTASIS; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NEOPLASM; PATHOLOGY; REFERENCE VALUE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; OTORHINOLARYNGOLOGIC NEOPLASMS; REFERENCE VALUES; SELENIUM; SPECTROPHOTOMETRY, ATOMIC;

EID: 56149095761     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1867-6     Document Type: Article

References (37)

1. Antila HM, Salo MS, Nanto V, et al. The effect of postoperative radiotherapy on leucocyte zinc, serum trace elements and nutritional status of breast cancer patients. Acta Oncol 1992;31:569-72.
2. Becker G, Momm F, Xander C, et al. Religious belief as a coping strategy: an explorative trial in patients irradiated for head-and-neck cancer. Strahlenther Onkol 2006;182:270-6.
3. Bhuvarahamurthy V, Balasubramanian N, Govindasamy S. Effect of radiotherapy and chemoradiotherapy on circulating system of human uterine cervical carcinoma. Mol Cell Biochem 1996;158:17-23.
4. Borek C. Antioxidants and radiation therapy. J Nutr 2004;134:3207-9.
5. Breccia A, Badiello R, Trenta A, et al. On the chemical radioprotection by organic selenium compounds in vivo. Radiat Res 1969;38:483-92.
6. Büntzel J, Micke O, Glatzel M, et al. Serum selenium in head and neck cancer patients - a new marker of tumor activity? Anticancer Res 2005;25:1711-2.
7. Calautti P, Moschini G, Stievano BM, et al. Serum selenium levels in malignant lymphoproliferative diseases. Scand J Haematol 1980;24:63-6.
8. Cao S, Durrani FA, Rustum YM. Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts. Clin Can Res 2004;10:2561-9.
9. Damron TA, Spadaro JA, Horton JA, et al. Novel radioprotectant drugs for sparing radiation induced damage to the physis. Int J Radiat Biol 2004;80:217-28.
10. Dörr W. Effects of selenium on radiation responses of tumor cells and tissue. Strahlenther Onkol 2006;182:693-5.
11. Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer 1998;83:777-82.
12. Fakih M, Cao S, Durrani FA, et al. Selenium protects against toxicity induced by anticancer drugs and augments antitumor activity: a highly selective, new and novel approach for the treatment of solid tumors. Clin Colorectal Cancer 2005;5:132-5.
13. Gehrisch A, Dörr W. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa. Strahlenther Onkol 2007;183:36-42.
14. Hoeller U, Biertz I, Flinzberg S, et al. Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity. Strahlenther Onkol 2006;182:157-63.
15. Husbeck B, Peehl DM, Knox SJ. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing. Free Radic Biol Med 2005;38:50-7.
16. Kiremidjian-Schumacher L, Roy M, Glickman R, et al. Selenium and immunocompetence in patients with head and neck cancer. Biol Trace Elem Res 2000;73:97-111.
17. Koskelo EK. Serum selenium in children during anti-cancer chemotherapy. Eur J Clin Nutr 1990;44:799-802.
18. Ladas EJ, Jacobson JS, Kennedy DD, et al. Antioxidants and cancer therapy: a systematic review. J Clin Oncol 2004;22:517-28.
19. Last K, Cornelius V, Delves T. Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma. J Clin Oncol 2003;21:2335-41.
20. Lopez-Saez J-B, Senra-Varela A, Pousa-Estevez L. Selenium in breast cancer. Oncology 2003;64:227-31.
21. Micke O, Mücke R, Bruns F, et al. Some clinical results on selenium in radiation oncology. Strahlenther Onkol 2007;183:344-5.
22. Milde D, Novak O, Stuka V, et al. Serum levels of selenium, manganese, copper and iron in colorectal cancer patients. Biol Trace Elem Res 2001;79:107-14.
23. Muecke R, Micke O, Schoenekaes KG, et al. Is a supplementation of selenium advisable during radiotherapy and radiochemotherapy of patients with malignant diseases? Trace Elem Electrolytes 2000;17:194-95.
24. Patchen ML, MacVittie TJ, Weiss JF. Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys 1990;18:1069-75.
25. Pothier L, Lane WW, Bhargava A, et al. Plasma selenium levels in patients with advanced upper gastrointestinal cancer. Cancer 1987;60:2251-60.
26. Rodemann HP, Hehr T, Bamberg M. Relevance of the radioprotective effect of sodium selenite. Med Klin 1999;94:39-41.
27. Schleicher UM, Lopez Cotarelo C, Andreopoulos D, et al. Radioprotection of human endothelial cells by sodium selenite. Med Klin 1999;94:35-8.
28. Schönekaes K, Micke O, Mücke R, et al. Use of complementary/alternative medicine by patients with breast carcinoma. Forsch Komplementärmed Klass Naturheilkd 2003;10:304-8.
29. Schueller P, Puettmann S, Micke O, et al. Selenium influences the radiation sensitivity of C6 rat glioma cells. Anticancer Res 2004;24:2913-7.
30. Shamberger RJ, Frost DV. Possible protective effect of selenium against human cancer. Can Med Assoc J 1969;100:682.
31. Shimazu F, Tappel AL. Selenoamino acids as radiation protectors in vitro. Radiat Res 1964;23:210-7.
32. Sundstrom H, Yrjanheikki E, Kauppila A. Serum selenium in patients with ovarian cancer during and after therapy. Carcinogenesis 1984;5:731-4.
33. Vernie LN, de Goeij JJ, Zegers C, et al. Cisplatin-induced changes of selenium levels and glutathione peroxidase activities in blood of testis tumor patients. Cancer Lett 1988;40:83-91.
34. Weijl NI, Hopman GD, Wipkink-Bakker A, et al. Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients. Ann Oncol 1998;9:1331-7.
35. Winnefeld K, Dawczynski H, Schirrmeister W, et al. Selenium in serum and whole blood in patients with surgical interventions. Biol Trace Elem Res 1995;50:149-55.
36. Yadav SP, Gera A, Singh I, et al. Serum selenium levels in patients with head and neck cancer. J Otolaryngol 2002;31:216-9.
37. Zachara BA, Marchaluk-Wisniewska E, Maciag A, et al. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients. Lung 1997;175:321-32.